A Key Major Guideline for Engineering Bioactive Multicomponent Nanofunctionalization for Biomedicine and Other Applications: Fundamental Models Confirmed by Both Direct and Indirect Evidence

Table 3

Bending length and crease recovery angle of different samples.

Sample code	Bending length (cm)		Crease recovery angle (warp) (°)		Crease recovery angle (weft) (°)
	Before XPs; treatment	After XPs; treatment	Before XPs; treatment	After XPs; treatment	Before XPs; treatment	After XPs treatment
C	5.4	5.7	121	134	122	131
M.C	6.2	5.7	135	131	120	126
NL	5.6	5.4	101	122	111	128
ONL	5.3	5.3	107	132	109	126
M.NL	6.3	5.6	115	126	109	134
M.ONL	6.2	5.8	116	118	120	134
NP	5.2	5.4	110	128	119	126
M.NP	6.4	5.7	103	115	105	128
NL/NP	4.2	5.2	105	10	107	116
ONL/NP	5.5	5.1	108	130	114	116
M.NL/NP	6.3	5.8	109	124	113	121
M.ONL/NP	6.1	5.6	116	120	103	123